Abstract: A process for removing Co2+, Pb2+, Cd2+ and Cr3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Sr2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Hg2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula: AmTiNbaSixOy. A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.

Abstract: A process for removing Hg2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with a titanium metallate ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The titanium metallate ion exchangers are represented by the following empirical formula: AmTiNbaSixOy. A composition is provided with the combination of the titanium metallate ion exchanger and bodily fluids or dialysis solutions. Also, provided is an apparatus comprising a matrix and the titanium metallate ion exchanger.

Abstract: A process for removing Sr2+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchanger to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchanger. The ion exchangers are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A process for removing Co2+, Pb2+, Cd2+ and Cr3+ toxins from bodily fluids is disclosed. The process involves contacting the bodily fluid with an ion exchange composition to remove the metal toxins in the bodily fluid, including blood and gastrointestinal fluid. Alternatively, blood can be contacted with a dialysis solution which is then contacted with the ion exchange composition. The ion exchange compositions are represented by the following empirical formula: AmZraTibSncMdSixOy. A composition comprising the above ion exchange compositions in combination with bodily fluids or dialysis solution is also disclosed. The ion exchange compositions may be supported by porous networks of biocompatible polymers such as carbohydrates or proteins.

Abstract: A method of making and using a new family of crystalline microporous metalloalumino(gallo)phosphosilicate molecular sieves is disclosed. These molecular sieves have been synthesized and are designated high charge density (HCD) MeAPSOs. These metalloalumino(gallo)phosphosilicates are represented by the empirical formula of: Rp+rA+mM2+wExPSiyOz where A is an alkali metal such as potassium, R is at least one quaternary ammonium cation such as ethyltrimethylammonium, M is a divalent metal such as Zn and E is a trivalent framework element such as aluminum or gallium. This family of metalloalumino(gallo)phosphosilicate materials is stabilized by combinations of alkali and quaternary ammonium cations, enabling unique, high charge density compositions. The HCD MeAPSO family of materials have catalytic properties for carrying out various hydrocarbon conversion processes and separation properties for separating at least one component.

Abstract: A method of making and using a new family of crystalline microporous metalloalumino(gallo)phosphosilicate molecular sieves is disclosed. These molecular sieves have been synthesized and are designated high charge density (HCD) MeAPSOs. These metalloalumino(gallo)phosphosilicates are represented by the empirical formula of: Rp+rA+mM2+wExPSiyOz where A is an alkali metal such as potassium, R is at least one quaternary ammonium cation such as ethyltrimethylammonium, M is a divalent metal such as Zn and E is a trivalent framework element such as aluminum or gallium. This family of metalloalumino(gallo)phosphosilicate materials is stabilized by combinations of alkali and quaternary ammonium cations, enabling unique, high charge density compositions. The HCD MeAPSO family of materials have catalytic properties for carrying out various hydrocarbon conversion processes and separation properties for separating at least one component.

Abstract: Manganese(IV)-containing oxides are effective catalysts for oxidation of water-soluble cyanide over a wide pH range (0.5-12) and temperature (15.degree.-250.degree. C.). Oxygen is the preferred oxidizing agent at partial pressures between about 0.2 and 5 atmospheres (2.9-75 psi, 20-517 kPa). Electrolytically deposited MnO.sub.2 is one preferred form of the catalyst. Another preferred manganese(IV)-containing oxide is the group of cation-stabilized manganese(IV)-containing oxides illustrated by cryptomelane. Yet another preferred form of manganese(IV)-containing oxide is a group of crystalline manganese phosphate compositions having an extended network and an empirical composition on an anhydrous basis expressed by an empirical formula of:(A.sup.a+).sub.v (Mn.sup.b+)(M.sup.c+).sub.x P.sub.y O.sub.